CIK 0001367083 · Non-accelerated filer<br>Smaller reporting company
Sonoma Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SNOA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680423298
- Phone
- 800-759-9305
- Business address
- 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
- Former names
- Oculus Innovative Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-02 | Weigerstorfer Philippe Director | Grant or award · Stock option (right to buy) | +7,500 | 10,001 | ||
| 2025-01-02 | DVONCH JEROME J Chief Financial Officer | Grant or award · Restricted Stock Units | +10,000 | 15,891 | ||
| 2025-01-02 | Dal Poggetto John Controller | Grant or award · Restricted Stock Units | +7,500 | 10,250 | ||
| 2024-06-20 | Trombly Amy Moss Chief Executive Officer | Grant or award | +53,586 | 153,586 | ||
| 2024-06-20 | Thornton Bruce Executive Vice President | Grant or award | +53,586 | 154,411 | ||
| 2024-06-20 | DVONCH JEROME J Chief Financial Officer | Grant or award | +53,586 | 84,595 | ||
| 2024-06-20 | Dal Poggetto John Controller | Grant or award | +15,000 | 15,000 | ||
| 2023-12-29 | Trombly Amy Moss Chief Executive Officer | Grant or award · Stock option (right to buy) | +60,000 | 173,648 | ||
| 2023-12-29 | Thornton Bruce Executive VP & COO | Grant or award · Stock option (right to buy) | +60,000 | 176,781 | ||
| 2023-12-29 | Dal Poggetto John Controller | Grant or award · Stock option (right to buy) | +50,000 | 55,000 | ||
| 2023-12-29 | DVONCH JEROME J Interim CFO | Grant or award · Stock option (right to buy) | +60,000 | 117,777 | ||
| 2023-06-30 | Trombly Amy Moss Chief Executive Officer | Grant or award | +100,000 | 213,648 | ||
| 2023-06-30 | Thornton Bruce Executive Vice President | Grant or award | +100,000 | 216,781 | ||
| 2022-12-29 | White Chad Norman Chief Financial Officer | Grant or award · Stock option (right to buy) | +9,753 | 14,753 | ||
| 2022-12-29 | Weigerstorfer Philippe Director | Grant or award · Stock option (right to buy) | +20,000 | 50,000 | ||
| 2022-12-29 | Trombly Amy Moss Chief Executive Officer | Grant or award · Stock option (right to buy) | +40,000 | 113,648 | ||
| 2022-12-29 | Thornton Bruce Chief Operating Officer | Grant or award · Stock option (right to buy) | +40,000 | 116,781 | ||
| 2022-12-29 | MCLAUGHLIN JOHN Director | Grant or award · Stock option (right to buy) | +20,000 | 53,252 | ||
| 2022-12-29 | Birnbaum Jay E Director | Grant or award · Stock option (right to buy) | +20,000 | 52,904 | ||
| 2022-01-14 | Weigerstorfer Philippe Director | Grant or award · Stock option (right to buy) | +30,000 | 30,000 |
Page 2 of 7 · 127 trades